Patents by Inventor Sanda Predescu

Sanda Predescu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GrB-EHinhibitory peptides
    Patent number: 10793598
    Abstract: Fusion peptides and methods of inhibiting GrB-EHITSN or a fragment thereof are provided. The fusion peptides include an NPF peptide and a cell-permeable peptide operably connected thereto. Fusion peptides and methods of inhibiting activity of GrB-EHITSN or fragment thereof are provided. An aspect includes a fusion peptide comprising an isolated NPF peptide comprising an amino acid sequence having at least 90% identity to SEQ ID NO: 2 and a cell-permeable peptide operably connected to the isolated NPF peptide, wherein the fusion peptide inhibits activity of GrB-EHITSN or a fragment thereof.
    Type: Grant
    Filed: June 19, 2015
    Date of Patent: October 6, 2020
    Assignee: Rush University Medical Center
    Inventors: Sanda Predescu, Dan Predescu
  • GrB-EHITSN Inhibitory Peptides
    Publication number: 20170129923
    Abstract: Fusion peptides and methods of inhibiting GrB-EHITSN or a fragment thereof are provided. The fusion peptides include an NPF peptide and a cell-permeable peptide operably connected thereto. Fusion peptides and methods of inhibiting activity of GrB-EHITSN or fragment thereof are provided. An aspect includes a fusion peptide comprising an isolated NPF peptide comprising an amino acid sequence having at least 90% identity to SEQ ID NO: 2 and a cell-permeable peptide operably connected to the isolated NPF peptide, wherein the fusion peptide inhibits activity of GrB-EHITSN or a fragment thereof.
    Type: Application
    Filed: June 19, 2015
    Publication date: May 11, 2017
    Applicant: Rush University Medical Center
    Inventors: Sanda Predescu, Dan Predescu